Diversified Trust’s Oncternal Therapeutics ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-14
Closed -$15K – 258
2016
Q3
$15K Hold
14
– – ﹤0.01% 276
2016
Q2
$10K Sell
14
-10
-42% -$9.35K ﹤0.01% 377
2016
Q1
$17K Buy
+24
New +$20.8K ﹤0.01% 384
2013
Q4
$50K Sell
21
-55
-72% -$126K 0.01% 454
2013
Q3
$217K Buy
+76
New +$378K 0.02% 440

Other funds holding ONCT

Diversified Trust's ONCT Position: Q4 2016 in Review

Diversified Trust sold out of Oncternal Therapeutics (ONCT) in Q4 2016, closing a stake of 14 shares — an estimated $15K sold.

Diversified Trust first reported a position in ONCT in Q3 2013 and held it in 5 quarters. The position peaked at $217K in Q3 2013. 21 funds tracked by Wall St. Rank hold ONCT as of Q4 2016.

  • Diversified Trust reported no remaining Oncternal Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Diversified Trust sold 14 Oncternal Therapeutics shares in Q4 2016, an estimated $15K.
  • Diversified Trust first reported a position in Oncternal Therapeutics in Q3 2013 and held it in 5 quarters.
  • Diversified Trust's Oncternal Therapeutics position peaked at $217K in Q3 2013.
  • 21 funds tracked by Wall St. Rank held Oncternal Therapeutics as of Q4 2016.

Based on Diversified Trust's 13F filing for Q4 2016, filed 22 Feb 2017.